Time-based understanding of DLCO and DLNO

Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19

A decreased lung diffusing capacity for carbon monoxide (DL_CO ) has been reported in a variable proportion of subjects over the first 3 months of recovery from severe coronavirus disease 2019 (COVID-19). In this study, we investigated whether measurement of lung diffusing capacity for nitric oxide (DL_NO ) offers additional insights on the presence and mechanisms of gas transport abnormalities. In 94 subjects, recovering from mild-to-severe COVID-19 pneumonia, we measured DL_NO and DL_CO between 10 and 266 days after each patient was tested negative for severe acute respiratory syndrome coronavirus 2. In 38 subjects, a chest computed tomography (CT) was available for semiquantitative analysis at six axial levels and automatic quantitative analysis of entire lungs. DL_NO was abnormal in 57% of subjects, independent of time of lung function testing and severity of COVID-19, whereas standard DL_CO was reduced in only 20% and mostly within the first 3 months. These differences were not associated with changes of simultaneous DL_NO /DL_CO ratio, while DL_CO /V_A and DL_NO /V_A were within normal range or slightly decreased. DL_CO but not DL_NO positively correlated with recovery time and DL_CO was within the normal range in about 90% of cases after 3 months, while DL_NO was reduced in more than half of subjects. Both DL_NO and DL_CO inversely correlated with persisting CT ground glass opacities and mean lung attenuation, but these were more frequently associated with DL_NO than DL_CO decrease. These data show that an impairment of DL_NO exceeding standard DL_CO may be present during the recovery from COVID-19, possibly due to loss of alveolar units with alveolar membrane damage, but relatively preserved capillary volume. Alterations of gas transport may be present even in subjects who had mild COVID-19 pneumonia and no or minimal persisting CT abnormalities. TRIAL REGISTRY: ClinicalTrials.gov PRS: No.: NCT04610554 Unique Protocol ID: SARS-CoV-2_DLNO 2020.

Modeling of Gas Exchange in the Lungs

This overview presents the recent progress in our understanding of gas transfer by the lungs during the respiratory cycle and during breath holding. Different phenomena intervene in gas transfer, convection and diffusion in the gas, dissolution, diffusion across the alveolar-capillary membrane, diffusion across blood plasma, and finally diffusion and reaction with hemoglobin inside blood cells. The different gases, O₂ , CO, and NO, have very different reaction times with hemoglobin ranging from a few microseconds to tens of milliseconds. This is leading to different outcomes. For O₂ , the solutions to the coupled nonlinear gas and blood equations are obtained at the acinus level. They include the fact that the acinar internal ventilation is strongly heterogeneous due to the arborescent structure. Also, in the dynamic calculation, one takes care of the delay between the start of inhalation and arrival of fresh air in the acinus. This "dead" time is the dynamic equivalent of the dead space ventilation. The question of the dependence of Vo₂ on ventilation and perfusion takes a different form. The results show that Vo₂ is not only a function of the ventilation/perfusion ratio but also depends on the variables: acinar ventilation VE_ac and perfusion Q_ac . The ratio VE_ac /Q_ac roughly determines arterial O₂ saturation and arterial and alveolar O₂ partial pressure. The classic Roughton-Forster interpretation of DLCO (separation between independent membrane and blood resistance) was a mathematical conjecture. It was shown recently that this conjecture was violated. This article presents an alternative interpretation that uses time concepts instead of resistance. © 2021 American Physiological Society. Compr Physiol 11:1289-1314, 2021.

Can DLNO/DLCO ratio offset prejudicial effects of functional heterogeneities in acinar regions?

OBJECTIVES

(1) To establish the general equation that describes relationship of DM_CO/Vc versus DL_NO/DL_CO under conditions with no functional heterogeneities. (2) To examine the effects of functional heterogeneities, including parallel and series (stratified) heterogeneities, on DL_NO/DL_CO.

RESULTS AND DISCUSSIONS

(1) Given that "true" θ_NO in pulmonary capillaries is represented by surface absorption-related θ_NO, relationship between DM_CO/Vc and DL_NO/DL_CO does not differ significantly from that obtained on premise of infinite θ_NO. DL_NO/DL_CO decided physiologically may mirror morphometric DM_CO/Vc actually working for gas exchange but not "total" morphometric ratio of DM_CO/Vc. (2) There are three parallel heterogeneities that affect diffusing capacity (D)-related parameters. Of them, only the heterogeneity of D/V_A, where V_A is alveolar volume, underestimates DL_CO and DL_NO. DL_NO/DL_CO does not alleviate negative impact of D/V_A heterogeneity, indicating that DM_CO/Vc estimated from DL_NO/DL_CO does not mirror "true" morphometric DM_CO/Vc in diseased lungs with D/V_A maldistribution. (3) Stratified heterogeneity underrates morphometric DM_CO, DM_NO, and DM_NO/DM_CO maximally by 1.4 %, 2.8 %, and 1.4 %, respectively, under conditions similar to single-breath D measurements, suggesting that effect of stratified heterogeneity on D measures is no longer needed to be considered in normal subjects but may be in patients having lung diseases with destructive lesions of acinar structures.

Value of lung diffusing capacity for nitric oxide in systemic sclerosis

A decreased lung diffusing capacity for carbon monoxide (DL_CO ) in systemic sclerosis (SSc) is considered to reflect losses of alveolar membrane diffusive conductance for CO (DM_CO ), due to interstitial lung disease, and/or pulmonary capillary blood volume (V_C ), due to vasculopathy. However, standard DL_CO does not allow separate DM_CO from V_C . Lung diffusing capacity for nitric oxide (DL_NO ) is considered to be more sensitive to decrement of alveolar membrane diffusive conductance than DL_CO . Standard DL_CO and DL_NO were compared in 96 SSc subjects with or without lung restriction. Data showed that DL_NO was reduced in 22% of subjects with normal lung volumes and DL_CO , whereas DL_CO was normal in 30% of those with decreased DL_NO . In 30 subjects with available computed tomography of the chest, both DL_CO and DL_NO were negatively correlated with the extent of pulmonary fibrosis. However, DL_NO but not DL_CO was always reduced in subjects with ≥ 5% fibrosis, and also decreased in some subjects with < 5% fibrosis. DM_CO and V_C partitioning and Doppler ultrasound-determined systolic pulmonary artery pressure could not explain individual differences in DL_CO and DL_NO . DL_NO may be of clinical value in SSc because it is more sensitive to DM_CO loss than standard DL_CO , even in nonrestricted subjects without fibrosis, whereas DL_CO partitioning into its subcomponents does not provide information on whether diffusion limitation is primarily due to vascular or interstitial lung disease in individual subjects. Moreover, decreased DL_CO in the absence of lung restriction does not allow to suspect pulmonary arterial hypertension without fibrosis.

What are appropriate values of relative krogh diffusion Constant of NO against CO and of theta-NO in alveolar septa?

OBJECTIVES

To propose new physical constants for NO and CO (Krogh diffusion constant ratio (KD_NO/CO) and specific blood conductance for NO (θ_NO)) for calculating DMCO and Vc, according to Roughton-Forster's equation (Roughton and Forster, J. Appl. Physiol. 11: 290-302, 1957) from simultaneous DLNO and DLCO measurements.

RESULTS AND CONCLUSIONS

(1) The Graham's law is unacceptable for determining KD_NO/CO because CO does not fulfil all the conditions of an "ideal" gas. We have re-estimated KD_NO/CO in a new way based on difference in molar volumes of two gases (molar volume theory). The KD_NO/CO thus decided is 2.34. (2) θ_NO measured with rapid-reaction, constant-flow method by Carlsen and Comroe (J. Gen. Physiol. 42: 83-107, 1958) may be underestimated by about 40 % due to unstirred water layer surrounding the erythrocyte. (3) Erythrocyte θ_O2 can be harvested from O₂ release kinetics in presence of high concentration of dithionite, which effectively removes the unstirred water layer-elicited effect. Multiplication of erythrocyte θ_O2 by erythrocyte KD_NO/O2 equals erythrocyte θ_NO, the value of which is 6.2 mL/min/mmHg/(mL⋅blood). According to the concepts of Kang et al. (RESPNB. 241: 62-71, 2017) and Borland et al. (RESPNB. 241: 58-61, 2017), in vitro θ_NO decided from rapid-mixing experiments may mirror bulk absorption of NO by erythrocytes. (4) In pulmonary capillaries, NO uptake takes place predominantly in the surface rim of the erythrocyte. This surface absorption of NO increases the θ_NO 10-fold versus bulk absorption of NO to about 60 mL/min/mmHg/(mL⋅blood).

Lung Diffusing Capacities (DL ) for Nitric Oxide (NO) and Carbon Monoxide (CO): The Evolving Story

Nitric oxide and carbon monoxide diffusing capacities (D_LNO and D_LCO ) obey Fick's First Law of Diffusion and the basic principles of chemical kinetic theory. NO gas transfer is dominated by membrane diffusion (D_M ), whereas CO transfer is limited by diffusion plus chemical reaction within the red cell. Marie Krogh, who pioneered the single-breath measurement of D_LCO in 1915, believed that the combination of CO with red cell hemoglobin (Hb) was instantaneous. Roughton and colleagues subsequently showed, in vitro, that the reaction rate was finite, and prolonged in the presence of high P O 2 . Roughton and Forster (R-F) proposed that the resistance to transfer (1/D_L ) was the sum of the membrane resistance (1/D_M ) and (1/θVc), the red cell resistance (θ being the CO or NO conductance for blood uptake and Vc the capillary volume). From this R-F equation, D_M for CO and Vc can be solved with simultaneous NO and CO inhalation. At near maximum exercise, D_MCO and Vc for normal subjects were 88% and 79%, respectively, of morphometric values. The validity of these calculations depends on the values chosen for θ for CO and NO, and on the diffusivity of NO versus CO. Recent mathematical modeling suggests that θ for NO is "effectively" infinite because NO reacts only with Hb in the outer 0.1 μM of the red cell. An "infinite θ_NO " recalculation reduced D_MCO to 53% and increased Vc to 95% of morphometric values. © 2020 American Physiological Society. Compr Physiol 10:73-97, 2020.

Diffusion Reaction of Carbon Monoxide in the Human Lung

The capture of CO, a standard lung function test, results from diffusion-reaction processes of CO with hemoglobin inside red blood cells (RBCs). In its current understanding, suggested by Roughton and Forster in 1957, the capture is represented by two independent resistances in series, one for diffusion from the gas to the RBC periphery, the second for internal diffusion reaction. Numerical studies in 3D model structures described here contradict the independence hypothesis. This results from two different theoretical reasons: (i) The RBC peripheries are not equi-concentrations; (ii) diffusion times in series are not additive.

Reappraisal of DLCO adjustment to interpret the adaptive response of the air-blood barrier to hypoxia

DLCO measured in hypoxia must be corrected due to the higher affinity (increase in coefficient θ) of CO with Hb. We propose an adjustment accounting for individual changes in the equation relating DLCO to subcomponents Dm (membrane diffusive capacity) and Vc (lung capillary volume): 1/DLCO=1/Dm+1/θVc. We adjusted the individual DLCO measured in hypoxia (HA, 3269m) by interpolating the 1/DLCO to the sea level (SL) 1/θ value. Nineteen healthy subjects were studied at SL and HA. Based on the proposed adjustment, DLCO increased in HA in 53% of subjects, reflecting the increase in Dm that largely overruled the decrease in Vc. We hypothesize that a decrease in Vc (buffering microvascular filtration) and the increase in Dm (possibly resulting from a decrease in thickness of the air-blood barrier) represent the anti-edemagenic adaptation of the lung to hypoxia exposure. The efficiency of this adaptation varied among subjects as DLCO did not change in 31% of subjects and decreased in 16%.